AAIC 2025 to Feature Lecanemab Data on Long-Term Efficacy, Real-World Use, and Maintenance Dosing
Eisai will present four-year safety and efficacy data, real-world use patterns, and findings on a new subcutaneous formulation for maintenance treatment in early Alzheimer disease.
What is Precision Neurocognition? David J Libon, PhD, Provides an Overview
Libon, a professor at the New Jersey Institute for Successful Aging at Rowan University, says the refined approach to cognitive assessment is widely available.
World Brain Day 2025: 9 Studies on Alzheimer Disease and Related Dementias Chosen for Primary Care
World Brain Day is celebrated on July 22 every year. In recognition Patient Care has summarized 9 notable studies of key interest to primary care for quick review.
Monu Khanna, MD, on the Unique Role of Primary Care in Managing Cardiometabolic Disease
Dr Khanna discusses how PCPs can use patient relationships to tailor lifestyle advice and manage obesity-related cardiometabolic disease.
Needle-Free Epinephrine Nasal Spray Shows Promise in Pediatric Food Allergy Anaphylaxis
Neffy, a needle-free epinephrine nasal spray, showed promise as a safe alternative for treating anaphylaxis in children with food allergies in a phase 3 trial.
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings
Atopic dermatitis flares should be factored in to an assessment of disease severity and prognosis, the authors note, and a threshold established for acceptable frequency.
17 Vaccines for Adults: Who to Consider for Each
A review of 4 factors can help primary care clinicians with an initial decision about adult vaccination: health, age, lifestyle, and occupation (HALO).
Roche's Investigational Anti-IL-33/ST2 Antibody for COPD Misses Phase 3 Primary Endpoint
Astegolimab did result in a statistically significant reduction of annualized exacerbation rates in a similar phase 2b trial, but the result was not replicated in phase 3.
FDA Advisory Committee Casts Nearly Unanimous Vote Against Otsuka's PTSD Combination
The FDA advisory committee overwhelmingly voted against Otsuka's PTSD treatment, citing insufficient evidence from clinical trials for approval.
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose
Your daily dose of the clinical news you may have missed.
Clinicians Who Tout Use of AI Risk Undermining Patient Trust, Study Finds
Clinicians who advertised use of AI for diagnostic, therapeutic, even administrative purposes were rated poorly on empathy, trustworthiness, and competence.
Digital Asthma Self Management Program Improves Symptom Control But Disparities in Benefit Are Clear
A smartphone-based asthma management program significantly enhanced symptom control, but may require engagement or cultural tailoring to expand the effect.
Shingrix Prefilled Syringe Gets FDA Greenlight, According to GSK
The prefilled syringe presentation streamlines administration of the vaccine, eliminating the need to combine the lyophylized antigen and separate adjuvant.
Phase 3 Trials Begin for Once-Monthly Oral HIV Prevention Pill
Merck has launched phase 3 trials for MK-8527, a promising once-monthly HIV prevention pill, aiming to enhance PrEP options globally.
Digital Latency Measures Refine Early Detection of Cognitive Decline: Expert Review of Evidence
Digital latency measures enhance early detection of cognitive decline, revealing neurodegenerative changes before traditional tests indicate impairment.
Treatment of Neuropathic Pain: A Close Look at a New Meta-Analysis
For the often treatment-resistant pain of neuropathic conditions, the meta-analysis includes updated evidence for both pharmacologic and neuromodulatory interventions.
Otsuka and Lundbeck Will Face Scrutiny Over Investigational PTSD Therapy at July 18 FDA AdComm Meeting
FDA's Psychopharmacologic Drugs Advisory Committee will evaluate the novel brexpiprazole/sertraline combination, weighing efficacy against existing therapies amid mixed trial results.
Pre- and Post-Menopausal Hormone Therapy Has Differential Effect on Breast Cancer Subtypes
Combined estrogen-progestin hormone therapy used to manage VMS of menopause was associated with a higher risk of developing luminal-like breast cancer subtypes and other subtypes.
Physicians Alarmed by Fad Diets on Social Media: Daily Dose
Monu Khanna, MD, on Why Cardiometabolic Screening Must Start Early in Patients with Obesity
Dr Khanna urges early screening for cardiometabolic risk in patients with obesity and highlights the role of primary care in prevention and education.
